Global Intrauterine Pressure Catheters Market Trends and Insights
Rising Complicated Pregnancies and High-Risk Labor Monitoring
The Intrauterine Pressure Catheter Market is affected by the growing number of labor cases that need closer observation. The share of early-term singleton births with induced labor rose from 17.7% in 2014 to 31.3% in 2024. This increase was 77% over the period and added to the number of cases where clinicians may need to calibrate oxytocin using uterine pressure data. Reported a sustained rise in gestational hypertension from 2016 through 2024, which added to the high-risk diagnoses managed in hospital labor units. In 2024, the U.S. maternal mortality rate for women aged 40 and older was 62.3 per 100,000 live births, nearly 5 times the rate for women under 25. These patterns keep direct contraction measurement relevant when labor risk, induction, and oxytocin use occur together.Evidence-Based Labor Management and Oxytocin Titration
The Intrauterine Pressure Catheter Market is reinforced by protocols that define when internal monitoring is clinically appropriate. ACOG defines active-phase arrest as no cervical progression after 4 hours of adequate uterine activity above 200 Montevideo Units or 6 hours of inadequate activity with oxytocin. The guideline strongly recommends an intrauterine pressure catheter for ruptured membranes and protracted active labor when contractions cannot be accurately measured externally. A 2025 review of 10 randomized trials covering more than 5,500 pregnancies found lower chorioamnionitis risk with high-dose oxytocin regimens, without a higher cesarean rate. The reported number needed to treat was 25. These findings support the use of pressure data when care teams need to apply oxytocin protocols consistently and document adequate uterine activity.Invasive Placement, Infection Risk and Limited Routine-Use Recommendations
The invasive nature of catheter placement limits the Intrauterine Pressure Catheter Market in low-risk and moderate-risk labor. ACOG described the supporting evidence as low quality despite its strong recommendation for the indicated patient group. The guideline also cited an AHRQ review that found no statistically significant difference from external monitoring in delivery mode, mean time to delivery, neonatal acidemia, or neonatal intensive care unit admission in comparable populations. This evidence allows clinicians to reserve the device for protracted labor instead of using it routinely. Infection-control reviews can require a clinical justification beyond protracted labor, which narrows the eligible use window. GE HealthCare’s Novii+ Wireless Patch Solution received FDA clearance in February 2024 and provides a noninvasive option for maternal and fetal monitoring in eligible cases.Other drivers and restraints analyzed in the detailed report include:
- Growing Maternal and Fetal Safety Awareness
- Expansion of Maternity Specialty Clinics and Developing-Region Access
- Connector Fragmentation, Disposable Waste and Total-Cost-of-Ownership Pressure
Segment Analysis
Catheters held 54.80% of revenue in 2026, making them the largest product system in the Intrauterine Pressure Catheter Market. Their position reflected their role as the direct physical link between the uterine cavity and the monitoring system. Catheter use remains necessary across fluid-filled, transducer-tipped, and advanced sensing approaches. This supports demand even when hospitals update their equipment. Cables and transducers contributed system revenue as reusable components with moderate replacement cycles. Disposables and accessories provided recurring expenditure with each procedure. The product mix, therefore, combined single-procedure consumption with equipment replacement and support needs.Monitoring equipment is forecast to grow at an 8.40% CAGR through 2032, the fastest rate within this segmentation. This part of the Intrauterine Pressure Catheter Market size reflects the wider value of connected monitoring platforms. GE HealthCare launched CareIntellect for Perinatal in October 2025 as a cloud-first application that consolidates uterine activity, fetal heart rate, SpO2, and blood pressure data from different bedside systems. The application was developed with input from 29 physicians and 85 nurses across 12 HCA Healthcare hospitals. The platform approach links equipment purchases with software-based services. It also shifts vendor competition toward data integration, remote visibility, and the compatibility of bedside systems.
Fluid-filled pressure transmission held 61.50% of revenue in 2026, the largest technology position in the Intrauterine Pressure Catheter Market. Long clinical familiarity, established installation practices, and lower acquisition costs supported this share. The installed base also helps hospitals continue using familiar systems. Fluid-filled technology can face reproducibility issues if air bubbles disrupt the pressure column. That problem can become more important during active labor when the catheter position changes. Transducer-tipped pressure sensing remained a meaningful middle tier for hospitals that sought a direct measurement approach with established products.
Advanced multi-parameter sensing is forecast to grow at a 10.2% CAGR through 2032, the fastest growth rate across the reported segment types. This Intrauterine Pressure Catheter Market size opportunity reflects demand for systems that combine uterine pressure with fetal ECG, maternal ECG, or real-time data transmission. Advanced platforms can command greater value where hospitals prioritize integrated surveillance. Utah Medical Products’ Intran Plus remained a widely deployed transducer-tipped intrauterine pressure catheter. Clinical Innovations received FDA clearance in May 2025 for its updated Koala Intrauterine Pressure Catheter, IPC-5000E. Air-coupled external transducer systems served facilities where membranes had not ruptured or internal monitoring was contraindicated.
Complete Report Scope:
- By Product System
- Catheters
- Cables & Transducers
- Monitoring Equipment
- Disposables & Accessories
- By Technology
- Fluid-Filled Pressure Transmission
- Transducer-Tipped Pressure Sensing
- Air-Coupled External Transducer Systems
- Advanced Multi-Parameter Sensing
- By Application
- Routine Labor Management
- High-Risk Pregnancy Monitoring
- Diagnostic & Therapeutic Procedures
- Research & Specialized Applications
- By End User
- Hospitals
- Specialty Clinics
- Birth Centers
- Academic & Research Institutions
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America held 41.80% of global revenue in 2026, the leading regional position in the Intrauterine Pressure Catheter Market. The United States supported this position through reimbursement for indicated labor monitoring, guideline use, and hospital purchasing systems that keep inventory in labor and delivery units. The United States recorded 3.6 million births in 2025. This was an increase from 17.7% in 2014. Canada benefited from provincial funding for advanced maternity monitoring, while Mexico showed procurement activity in urban institutional delivery centers.Europe was the second-largest revenue region in the Intrauterine Pressure Catheter Market. Germany, the United Kingdom, and France had mature clinical infrastructure and evidence-based obstetric protocols. National health systems supported catheter use in indicated cases. German facilities were adopting cloud-connected dashboards that combine uterine pressure data with fetal heart rate and nurse-call workflows. Nordic and the United Kingdom health systems showed interest in multi-parameter sensing platforms, where the clinical evidence supported the higher acquisition cost. Italy and Spain represented secondary markets with growing investment in specialist obstetric care.
Asia-Pacific is forecast to grow at a 9.80% CAGR through 2032, the fastest regional rate in the Intrauterine Pressure Catheter Market. India and China are the principal demand centers because private hospital capacity and tertiary obstetric care are expanding. India’s Pradhan Mantri Surakshit Matritva Abhiyan supports the national focus on maternal care. Japan’s medical-device database recorded 20 labor-monitoring devices in a Class II intrauterine pressure transducer category. The BT-350 labor-monitoring unit received Japanese regulatory certification in July 2024. South Korea and Australia were mature technology-accepting markets, while the Gulf Cooperation Council and South America added demand through maternity investment and distribution partnerships.
List of Companies Covered in this Report:
- Beckton Dickinson
- Cardinal Health
- Clinical Innovations LLC
- Cook Group
- The Cooper Companies
- GE HealthCare Technologies Inc.
- Hologic
- Kentec Medical Inc.
- Koninklijke Philips
- Laborie
- MedGyn Products
- Medtronic
- Millar Inc.
- Natus Medical (Integra LifeSciences)
- Neoventa Medical AB
- Stryker
- Teleflex
- Terumo
- Thomas Medical
- Utah Medical Products
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Becton, Dickinson and Company
- Cardinal Health Inc.
- Clinical Innovations LLC
- Cook Medical LLC
- CooperSurgical Inc.
- GE HealthCare Technologies Inc.
- Hologic Inc.
- Kentec Medical Inc.
- Koninklijke Philips NV
- Laborie Inc.
- MedGyn Products Inc.
- Medtronic PLC
- Millar Inc.
- Natus Medical (Integra LifeSciences)
- Neoventa Medical AB
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
- Thomas Medical
- Utah Medical Products Inc.

